Spencer, Andrew ; Lentzsch, Suzanne ; Weisel, Katja...
Spencer , A , Lentzsch , S , Weisel , K , Avet-Loiseau , H , Mark , T M , Spicka , I , Masszi , T , Lauri , B , Levin , M D , Bosi , A , Hungria , V , Cavo , M , Lee , J J , Nooka , A K , Quach , H , Lee , C , Barreto , W , Corradini , P , Min , C K , Scott , E C , Chanan-Khan , A A , Horvath , N , Capra , M , Beksac , M , Ovilla , R , Jo , J C , Shin , H J , Sonneveld , P , Soong , D , Casneuf , T , Chiu , C , Amin , H , Qi , M , Thiyagarajah , P , Sasser , A K , Schecter , J M & Mateos , M V 2018 , ' Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma : Updated analysis of CASTOR ' , Haematologica , vol. 103 , no. 12 , pp. 2079-2087 . https://doi.org/10.3324/haematol.2018.194118.  , 2018